231 related articles for article (PubMed ID: 14998778)
1. Effectiveness of live varicella vaccine.
Takahashi M
Expert Opin Biol Ther; 2004 Feb; 4(2):199-216. PubMed ID: 14998778
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
[TBL] [Abstract][Full Text] [Related]
3. Varicella vaccine: the American experience.
Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated varicella vaccine.
Arvin AM; Gershon AA
Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
Gershon AA; Steinberg SP
J Infect Dis; 1990 Apr; 161(4):661-6. PubMed ID: 2156941
[TBL] [Abstract][Full Text] [Related]
6. Immunization of healthy adults with live attenuated varicella vaccine.
Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.
Gelb LD; Dohner DE; Gershon AA; Steinberg SP; Waner JL; Takahashi M; Dennehy PH; Brown AE
J Infect Dis; 1987 Apr; 155(4):633-40. PubMed ID: 3029239
[TBL] [Abstract][Full Text] [Related]
8. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
10. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
[TBL] [Abstract][Full Text] [Related]
11. Prospects for use of a varicella vaccine in adults.
Hardy IR; Gershon AA
Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261
[TBL] [Abstract][Full Text] [Related]
12. Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine.
Terada K; Niizuma T; Ogita S; Kataoka N
Vaccine; 2002 Nov; 20(31-32):3638-43. PubMed ID: 12399190
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
14. Varicella immunity in vaccinated healthcare workers.
Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
16. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
[TBL] [Abstract][Full Text] [Related]
17. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated varicella vaccine use in immunocompromised children and adults.
Gershon AA; Steinberg SP; Gelb L
Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
[TBL] [Abstract][Full Text] [Related]
19. Chickenpox party or varicella vaccine?
Hambleton S; Arvin AM
Adv Exp Med Biol; 2005; 568():11-24. PubMed ID: 16107063
[TBL] [Abstract][Full Text] [Related]
20. Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.
Field N; Amirthalingam G; Waight P; Andrews N; Ladhani SN; van Hoek AJ; Maple PA; Brown KE; Miller E
Vaccine; 2014 Feb; 32(10):1213-7. PubMed ID: 23871823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
